Mechanism of Action of Bimatoprost, Latanoprost, and Travoprost in Healthy Subjects
Kin Sheng Lim(Cheil General Hospital and Women's Healthcare Center), Douglas H. Johnson(Northern Prairie Wildlife Research Center), Jay W. McLaren, Cherie B. Nau(Mayo Clinic), David O. Hodge(WinnMed), Carol B. Toris(University of Nebraska Medical Center), Megan M. O’Byrne(Mayo Clinic)
Cited by 167
Related Papers
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
|PubMed|1997|771
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553
Ten-year postoperative results of penetrating keratoplasty
|Ophthalmology|1998|506
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
|Journal of Clinical Investigation|2020|485
Safety Update
|Mayo Clinic Proceedings|2020|432